TB-500 is the recovery peptide — a synthetic piece of a natural protein (thymosin beta-4) studied for helping cells migrate to injured tissue, build new blood vessels and speed healing. In animal research it has shown effects on wounds, muscle, tendon and even heart tissue.
It is popular with people chasing faster recovery, and often paired with BPC-157. The honest frame is the same as its partner’s: promising animal data, no controlled human trials, banned in sport, and sold for research only. Here is what the evidence supports.
What TB-500 is
TB-500 is a synthetic version of a key active region of thymosin beta-4 (Tβ4), a protein found throughout the body that plays a role in cell movement and tissue repair. By using the active fragment, researchers aim to capture Tβ4’s healing-related effects in a smaller, more practical molecule. For how it stacks up against the other famous repair peptide, see BPC-157 vs TB-500.
TB-500’s job, in one phrase, is to help repair cells get where they need to go. In animals that looks powerful — in humans it is still unproven.The recovery peptide’s promise and its caveat
How it works
Tβ4’s main known role is regulating actin, a protein essential to cell structure and movement. By influencing actin, TB-500 is thought to promote cell migration — letting repair cells travel to damaged areas — along with angiogenesis (new blood vessels) and reduced inflammation. Together, in theory, these support faster, more organized tissue repair. This is a different mechanism from BPC-157, which is part of why the two are researched together.
The benefits studied
| Area | What research suggests | Evidence |
|---|---|---|
| Wound healing | Faster closure, cell migration | Animal / lab |
| Muscle & soft tissue | Repair and recovery support | Animal |
| Tendon / ligament | Healing support (often with BPC-157) | Animal |
| Cardiac tissue | Protection/repair signals | Animal / preclinical |
| Flexibility / inflammation | Reduced inflammation, mobility | Anecdotal + animal |
TB-500 vs BPC-157
They are the two pillars of recovery research and attack repair from different angles: BPC-157 (a gastric peptide) is studied heavily for tendon, ligament and gut repair and angiogenesis; TB-500 (a thymosin fragment) is studied for cell migration, flexibility and broader tissue recovery. Because the mechanisms differ, they are often combined — and sold as a blend — though no human study confirms the pairing. The full comparison is in BPC-157 vs TB-500, and tendon-specific research in BPC-157 for tendons.
The limits
- No human trials. The recovery evidence is animal and anecdotal; there are no published controlled human trials of TB-500 for injury.
- Banned in sport. TB-500 is on the World Anti-Doping Agency prohibited list — tested athletes must avoid it.
- Unknown human safety. Long-term human safety has not been established, and injectable peptides are regulated as prescription drugs in Canada.
TB-500 is not an approved drug, has no controlled human trials for recovery, and is banned in sport under WADA. TrueLabs sells it for in vitro and laboratory research only. This article is research background, not medical advice or dosing guidance.
For researchers
TrueLabs supplies TB-500 from $55, BPC-157 from $22, and the BPC-157/TB-500 blend from $70, in CAD for in vitro and laboratory research only. Before ordering, see how to read a peptide COA and the COA library.
TB-500 myths
“Myth: TB-500 is clinically proven for recovery.”
The evidence is animal and anecdotal. There are no published controlled human trials for injury recovery.
“Myth: It builds muscle.”
It is studied for repair and cell migration, not hypertrophy. Any muscle benefit would be indirect via recovery.
“Myth: It is legal for athletes.”
No. TB-500 is on the WADA prohibited list; tested athletes must avoid it.
“Myth: The BPC/TB blend is proven synergistic.”
Combining them is a research rationale, not a demonstrated synergy in humans.
FAQ
Tap a question to reveal the answer.
What are the benefits of TB-500?
In animal and lab research it is studied for wound healing, muscle and soft-tissue repair, tendon healing, cardiac tissue and reduced inflammation, via its effects on cell migration. Human evidence is lacking.
Does TB-500 actually work for recovery?
Animal data are promising and users report benefits, but there are no controlled human trials, so its recovery effect in people is unproven.
How does TB-500 work?
It is based on thymosin beta-4 and regulates actin, promoting cell migration to injured tissue, new blood-vessel formation and reduced inflammation in research models.
Is TB-500 better than BPC-157?
They work differently and are often combined. BPC-157 leans toward tendon, ligament and gut repair; TB-500 toward cell migration and flexibility. Neither has human trials.
Is TB-500 banned in sport?
Yes. It is on the World Anti-Doping Agency prohibited list, so athletes subject to testing must avoid it.
Is TB-500 safe?
Long-term human safety has not been established in controlled trials. It is not an approved drug, and injectable peptides are prescription-regulated in Canada.
Can TB-500 and BPC-157 be used together?
They are often researched and sold as a blend on the theory they target complementary repair steps, but no human study confirms the combination.
Is research TB-500 a treatment?
No. It is a raw compound for laboratory study, not an approved or proven recovery treatment.
Related reading
- BPC-157 vs TB-500
- BPC-157 for tendons
- TB-500 side effects
- Best peptides for muscle growth
- Tendonitis research in Canada
References
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005.
- Health Canada. Advisory: unauthorized injectable peptide products, 2025.
This article summarizes published research for information only and is not medical advice. TrueLabs research compounds are sold for in vitro and laboratory research use only and are not intended for human or veterinary use.